PAR DRUGS AND CHEMICALS Financial Statement Analysis
|
||
|
The Revenues of PAR DRUGS AND CHEMICALS have increased by 27.54% YoY .
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has increased by 28.01 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PAR DRUGS AND CHEMICALS Last 5 Annual Financial Results
[NSE : PAR]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹96 Cr | ₹75 Cr | ₹61 Cr | ₹5,584,869 Cr | ₹46 Cr |
| Expenses | ₹78 Cr | ₹59 Cr | ₹45 Cr | ₹4,640,535 Cr | ₹38 Cr |
| Operating Profit (Excl OI) | ₹18 Cr | ₹16 Cr | ₹16 Cr | ₹944,333 Cr | ₹8.20 Cr |
| Other Income | ₹0.24 Cr | ₹0.18 Cr | ₹0.19 Cr | ₹10,392 Cr | ₹0.09 Cr |
| Interest | ₹0.13 Cr | ₹0.45 Cr | ₹0.64 Cr | ₹79,388 Cr | ₹1.96 Cr |
| Depreciation | ₹3.23 Cr | ₹3.28 Cr | ₹2.82 Cr | ₹276,151 Cr | ₹3.04 Cr |
| Profit Before Tax | ₹15 Cr | ₹13 Cr | ₹15 Cr | ₹599,186 Cr | ₹3.29 Cr |
| Profit After Tax | ₹11 Cr | ₹9.21 Cr | ₹12 Cr | ₹476,498 Cr | ₹2.51 Cr |
| Earnings Per Share (Rs) | ₹11.79 | ₹9.21 | ₹7.49 | ₹18.87 | ₹7.75 |
| PAT Margin (%) | 13.52 | 10.46 | 10.86 | 16.81 | 7.50 |
| ROE(%) | 18.49 | 17.29 | 16.44 | 25.02 | 13.68 |
| ROCE(%) | 25.02 | 23.20 | 21.85 | 28.68 | 15.56 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.16 | 0.15 |
Key Financials |
||
| Market Cap | : | ₹ 361.7 Cr |
| Revenue (TTM) | : | ₹ 104.1 Cr |
| Net Profit(TTM) | : | ₹ 18.3 Cr |
| EPS (TTM) | : | ₹ 14.9 |
| P/E (TTM) | : | 19.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PAR DRUGS AND CHEMICALS | 8.5% | 32.4% | 19% |
| PIDILITE INDUSTRIES | -2.1% | -5.4% | 17% |
| SOLAR INDUSTRIES INDIA | 0.4% | -7.2% | 34.8% |
| SRF | -3.1% | -0.5% | -9.3% |
| GUJARAT FLUOROCHEMICALS | -7% | -19.1% | 36.3% |
| DEEPAK NITRITE | 1.3% | 0.8% | 22.1% |
| TATA CHEMICALS | 1% | -6.5% | 8.2% |
| GODREJ INDUSTRIES | 10.7% | 1.8% | 52.6% |
| AARTI INDUSTRIES | -1.7% | -11.9% | -19.2% |
PAR DRUGS AND CHEMICALS Revenues
[NSE : PAR]
| Y-o-Y | 27.54 % |
| 5 Yr CAGR | 19.90 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹96 Cr | 27.54 | |
| Mar2023 | ₹75 Cr | 23.58 | |
| Mar2022 | ₹61 Cr | -100.00 | |
| Mar2021 | ₹5,584,869 Cr | 12,056,262.35 | |
| Mar2020 | ₹46 Cr | - | |
PAR DRUGS AND CHEMICALS Operating Profit
[NSE : PAR]
| Y-o-Y | 12.01 % |
| 5 Yr CAGR | 22.06 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹18 Cr | 12.01 | |
| Mar2023 | ₹16 Cr | 1.51 | |
| Mar2022 | ₹16 Cr | -100.00 | |
| Mar2021 | ₹944,333 Cr | 11,511,947.79 | |
| Mar2020 | ₹8.20 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -12.15 % |
| 5 Yr CAGR | 1.80 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 19.02% | -12.15 | |
| Mar2023 | 21.65% | -17.87 | |
| Mar2022 | 26.36% | 55.88 | |
| Mar2021 | 16.91% | -4.52 | |
| Mar2020 | 17.71% | - | |
PAR DRUGS AND CHEMICALS Profit After Tax
[NSE : PAR]
| Y-o-Y | 23.02 % |
| 5 Yr CAGR | 45.76 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹11 Cr | 23.02 | |
| Mar2023 | ₹9.21 Cr | -20.65 | |
| Mar2022 | ₹12 Cr | -100.00 | |
| Mar2021 | ₹476,498 Cr | 18,976,316.17 | |
| Mar2020 | ₹2.51 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 29.25 % |
| 5 Yr CAGR | 15.87 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 13.52 % | 29.25 | |
| Mar2023 | 10.46 % | -3.68 | |
| Mar2022 | 10.86 % | -35.40 | |
| Mar2021 | 16.81 % | 124.13 | |
| Mar2020 | 7.5 % | - | |
PAR DRUGS AND CHEMICALS Earnings Per Share (EPS)
[NSE : PAR]
| Y-o-Y | 28.01 % |
| 5 Yr CAGR | 11.06 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹12 | 28.01 | |
| Mar2023 | ₹9.21 | 22.96 | |
| Mar2022 | ₹7.49 | -60.31 | |
| Mar2021 | ₹19 | 143.48 | |
| Mar2020 | ₹7.75 | - | |
PAR DRUGS AND CHEMICALS Return on Capital Employed (ROCE)
[NSE : PAR]
| Y-o-Y | 7.84 % |
| 5 Yr CAGR | 12.61 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 25.02% | 7.84 | |
| Mar2023 | 23.2% | 6.18 | |
| Mar2022 | 21.85% | -23.81 | |
| Mar2021 | 28.68% | 84.32 | |
| Mar2020 | 15.56% | - | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Current Share Price | : | ₹294.1 |
| Current MarketCap | : | ₹ 361.7 Cr |
| Updated EOD on | : | Nov 22,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 8.5% |
32.4% |
19% |
| SENSEX | 1.8% |
-2.5% |
19.9% |
PAR DRUGS AND CHEMICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PAR DRUGS AND CHEMICALS Financials
How the annual revenues of PAR DRUGS AND CHEMICALS have changed ?
The Revenues of PAR DRUGS AND CHEMICALS have increased by 27.54% YoY .
How the Earnings per Share (EPS) of PAR DRUGS AND CHEMICALS have changed?
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has increased by 28.01 % YoY .
Check out Intrinsic Value of Peers of PAR DRUGS AND CHEMICALS
Compare Stock Analytics of Peers of PAR DRUGS AND CHEMICALS
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs
